Trial Profile
A phase II trial of gemcitabine (Gemzar) combined with vinorelbine as first line chemotherapy for metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2007
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Vinorelbine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 08 Aug 2007 Status change from in progress to completed.
- 27 Jul 2006 Status change
- 02 Nov 2005 New trial record.